"Orion Therapeutics, a Knoxville biotechnology company that has been operating in stealth mode for a little less than a year, has been selected to join the prestigious MassBioDrive accelerator program as a member of the 2022 cohort. The announcement was made yesterday, and the newest cohort includes two start-ups from Canada and one each from Connecticut, Massachusetts, and Nebraska."
Copyright © 2023 Orion Therapeutics - All Rights Reserved.
Powered by GoDaddy